Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
Fragment-Based Approach Increases Leads
Powerful and Complementary Methodology Allows Small Companies to Improve Discovery
- Researchers are increasingly relying upon fragment-based lead discovery in their search for novel and effective drug candidates. The approach utilizes a number of complementary technologies, with crystallography and structure-based drug design being two of these key techniques. Last month, “Fragment-Based Lead Discovery 2008” was held in San Diego. “It was ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.